Founder
Inhite Ventures
Join investors at the
Glucowear: Investor Briefing & Due Diligence Session
ABOUT EVENT
On June 24, we are inviting selected investors to a closed-door session on Glucowear, a next-generation pain-free, real-time glucose monitoring device designed to transform diabetes care into a more lifestyle-driven, user-empowered experience by Afon Technology Ltd.
The gathering will include a live Q&A session with the senior leadership and technical team (clinical, engineering, regulatory, and commercial), alongside existing investors, providing an opportunity for prospective investors to conduct due diligence and gain deeper insight into the company's clinical progress, regulatory pathway, manufacturing strategy and commercialization plans.
The company is raising a £7.5M Series A to support final trials, regulatory approvals, manufacturing scale-up and team expansion.
This is a 2-hour live video call starting at 7am PST, designed for focused due diligence and direct engagement with the founding team.
Participants
Founder and CEO
ATG Consulting
Private Investor
Private Investor
Managing Partner
Prakrit Advisors
Operational Partner Mexico
Zentynel Frontier Investments
Venture Partner
Genoa Ventures
CEO
The Metabolic Group
CEO
Maxima Markets
CEO
Afon Technology Ltd
REQUEST MEETINGS
Investors
Inhite Ventures
Founder
ATG Consulting
Founder and CEO
Private Investor
Private Investor
Zentynel Frontier Investments
Operational Partner Mexico
Genoa Ventures
Venture Partner
Activity Schedule
Asia/Dubai
Welcome & Investor Introductions
Brief introductions and overview of the session agenda.
Group Video Call
Glucowear Presentation
Presentation of the company, technology, milestones, and investment opportunity.
Group Video Call
Live Q&A & Due Diligence Session
Direct discussion with the leadership team and existing investors.
Group Video Call
Closing Remarks
Final questions, next steps, and follow-up opportunities.
Group Video Call